ACTR-54. OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED INTERVENTION WITH SKULL REMODELLING SURGERY TO MAXIMIZE LEVELS OF TTFIELDS INTENSITY FOR HIGHER TREATMENT BENEFIT - THE OPTIMAL TTF STUDY

We present an ongoing open label phase 1 investigator-sponsored trial (NCT02893137) testing safety/efficacy of a novel therapeutic concept for recurrent glioblastoma (GBM). The intervention combines best choice chemotherapy with tumor treating fields (TTFields) and personalized targeted skull remode...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Korshoej, Anders Rosendal, Hansen, Frederik Lundgaard, Slavka, Lukacova, Cortnum, Søren Ole Stigaard, Lassen-Ramshad, Yasmin, Guldberg, Trine Lignell, Rahbek, Christian, Mikic, Nikola, Thielscher, Axel, Sørensen, Jens Christian Hedemann, von Oettingen, Gorm Burckhardt
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2017
Schlagworte:
Abstracts
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692142/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.045
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge